Beijing Trade Star Medical Technology Development Co., Ltd. is a business entity with focuses on drug research & development and drug agency & sales. Trade Star follows the enterprise spirit of “Righteousness, Diligence, Far insight, and Expansionism” and in a few years, it has founded its leading position in the national pharmaceutical market of oral antibiotics and cardiovascular injections and established long-term cooperative relationships with many pharmaceutical companies, end-use hospitals, and business partners. The business scope of the company includes: research and development of both traditional and western medicines, medicinal promotion on the market, and global agency for new and unique drugs. Its sales network covers all major cities in China and there are representative offices around the country. Seven departments are established, which includes the R&D department, the sales department, the investment promotion department, the marketing department, the governmental affair department, the administration department, and the finance department. Approximately hundred staffs are employed, in which 90% are graduates with related degrees to medicine. The “R&D” department employs many experts and scholars with broad spectrum of professional knowledge in international medicines and their developing trends. Thus, our pharmaceutical research & development department has a solid foundation. The “Sales” department covers almost all the sales of products in local and military hospitals of secondary grade in Beijing, Tianjin, and Hebei Province, giving an annual sale of nearly 200 million Yuan. In which, the antibiotics of “Cephalosporin” and “Thymopentin for Injection” remain the top two of most used systemic drug. The “investment promotion” department is primarily in charge of national marketing of various newly developed products, including nationally insured and unique oral antibiotics like “Cefdinir Dispersible Tablets” and “Cefdinir Capsules”, classic neuronutritional drug “Monosialotetrahexosylganglioside for injection” ,and serial products for hepatic disease like “Adenosylmethionine” and “Polyene Phosphatidylcholine Injection”. These products arouse great response from around the country and reflect positively on our company’s effort to build a good brand and influence in pharmaceutical industry. The “marketing” department is responsible for early survey during the introductory period of a product and the overall monitoring until the maturation of its market sale. With sharp observation on the market sales, it can provide supportive data as evidences for selection of new product and management of products on market. The “governmental affair” department will cooperate closely with all governmental departments to provide strong background support for jobs in bidding, price report, free pricing, social security, and etc. The “administration” department will be in charge of the company’s offices and various departments such as the “business” department, the “purchasing” department, the “logistics” department, and the “bidding” department, as well as coordinating plans among these departments, in order to provide strong guarantee for the best customer service. The company provides standard management and legalized operating system for smooth liquidity of operational products. Currently, the company has invested and participated in business management with three medical and pharmaceutical companies in Beijing and Hebei Province. These enterprises manufacture drugs and medical devices (Class Ⅲ) and have achieved national GSP approval. The company is developing in multiple directions and fast growth rates are seen in each aspect. Average annual growth rate is above 40% and now, the company will attempt to extend its influence to other well-known foreign enterprises. In 2006, our company, after rigorous verification and approval by Beijing Bureau of Science Technology & Information, is honored with the Confirmation and Approval Certificate of “Beijing High-Tech Enterprise”, which labels us with creativity and great R&D skill in technology, as is recognized by authentic governmental department, too. It is of great significance to acknowledge our company as a creative enterprise in developing new technology. In current days of many chances as well as great challenges for medical industry and enterprises, developing Beijing Trade Star Medical Technology & Development Co., Ltd. is holding the very pulse of the market, and the insight of the developmental trend. With consistently following the business principle of “management first and creativity second”, as well as good team spirit, we can fully upgrade our enterprise culture to strive for the best and to expand creatively, in order to return the best to society and development of medical industry. Beijing Trade Star Medical Technology & Development Co., Ltd. is willing to cooperate with comrades around the world to walk together down the path to create a better tomorrow. 北京凯德思达医药科技发展有限公司是一家集药品研发、药品推广代理于一身的经营实体。凯德思达秉承“正德、勤奋、睿思、拓达”的企业精神,在短短几年内,已奠定了在全国口服抗菌素、心脑血管类针剂药品销售市场的领先地位,与制药企业、医院终端、商业伙伴之间建立了稳定扎实的关系网络。
公司经营范围包括:中、西药的新药科技开发及推广;代理国内外新药、特药。销售网络遍布全国各大城市,在各地均设有办事机构。 公司下设研发部、销售部、招商部、市场部、政府事务部、行政业务部、财务部7个部门,现有员工近百人,其中医药相关专业毕业的大专以上学历占90%。其中“研发部”汇聚了专业学识渊博,通晓国内外医药行业发展趋势的专家和学者,为我公司药品研发及新药上市奠定了坚实的基础;“销售部”产品几乎覆盖北京、天津、河北所有二甲以上地方及军队系统医院,年销售额2亿元左右,其中"头孢类抗生素"及"注射用胸腺五肽"一直保持着同类系统用药前二名的成绩。“招商部”主要负责公司研发合作产品的全国推广,其中全国医保、国内独家口服类抗菌素“头孢地尼分散片”和“头孢地尼胶囊”、经典神经营养用药“单唾液酸四己糖神经节苷脂注射剂”和"多烯脂酰胆碱注射液"、"腺苷蛋氨酸"等肝病系列产品已在全国各地引起强烈的反响,也大大地提升了公司的品牌及影响力!“市场部”由产品导入期的前期调查到成熟期的销售监测，以敏锐的市场眼光为公司新产品的选择、已营产品的管理提供了充足有力的数据支持;“政府事务部”与各级政府部门紧密配合,为公司经营产品的招标、物价备案、自主定价、社保等工作提供了强有力的后盾支持;“行政业务部”现负责公司办公室、商务部、采购部、物流部、招标办公室等部门,协调各个部门的工作,为全公司后勤服务提供了坚实的保障!
公司为操作产品的市场流通环节提供了管理规范化、合法化的操作平台。目前已在北京、河北三家医药公司入股参与了经营管理,这三家医药公司的药品及医疗器械 (Ⅲ类) 均是通过国家GSP认证的经营企业。
公司形成多元化发展,各项业务均取得了快速的增长,年均增长率在40%以上,现在又将触角延伸至国外知名企业。在二零零六年,我司经过北京市科技和信息局的严格审核,荣获“北京市高新技术企业认定证书”,标志着我司在科技创新和强大的研发能力方面获得了政府权威部门的认可,为我司创建科技创新型企业提供了强大的支持。
在医药行业和企业面临强大机遇与挑战的今天,发展中的北京凯德思达医药科技发展有限公司紧握市场脉搏,洞悉发展趋势,一如既往地遵循“以管理为经,以创新为纬”的经营哲学,充分发扬团队精神,全面提升企业文化,奋力拼搏,开拓创新,争取为医药事业的发展做出更大的贡献!
凯德思达愿与五湖四海的有识之士共求发展,共同进步,共创美好未来! |